navan
/
Daily-Dose
mirror of https://github.com/navanchauhan/Daily-Dose.git
1
0
Fork 0
Code Issues Projects Releases Wiki Activity

Added daily report

This commit is contained in:
Navan Chauhan 2023-06-09 12:45:55 +00:00
parent dc51799fcc
commit 1defa1dc6a
3 changed files with 623 additions and 2 deletions
Show Stats Download Patch File Download Diff File Expand all files Collapse all files

180
archive-covid-19/09 June, 2023.html Normal file
View File

@ -0,0 +1,180 @@
<!DOCTYPE html>
<html lang="" xml:lang="" xmlns="http://www.w3.org/1999/xhtml"><head>
<meta charset="utf-8"/>
<meta content="pandoc" name="generator"/>
<meta content="width=device-width, initial-scale=1.0, user-scalable=yes" name="viewport"/>
<title>09 June, 2023</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>
<title>Covid-19 Sentry</title><meta content="width=device-width, initial-scale=1.0" name="viewport"/><link href="styles/simple.css" rel="stylesheet"/><link href="../styles/simple.css" rel="stylesheet"/><link href="https://unpkg.com/aos@2.3.1/dist/aos.css" rel="stylesheet"/><script src="https://unpkg.com/aos@2.3.1/dist/aos.js"></script></head>
<body>
<h1 data-aos="fade-down" id="covid-19-sentry">Covid-19 Sentry</h1>
<h1 data-aos="fade-right" data-aos-anchor-placement="top-bottom" id="contents">Contents</h1>
<ul>
<li><a href="#from-preprints">From Preprints</a></li>
<li><a href="#from-clinical-trials">From Clinical Trials</a></li>
<li><a href="#from-pubmed">From PubMed</a></li>
<li><a href="#from-patent-search">From Patent Search</a></li>
</ul>
<h1 data-aos="fade-right" id="from-preprints">From Preprints</h1>
<ul>
<li><strong>Concerns about data integrity of 30 randomized clinical trials from one author.</strong> -
<div>
Introduction In 2021, we learnt about the problems in studies on ivermectin and hydrocholoroquine in COVID-19. We noticed an appreciable number of unfunded randomised clinical trials (RCTs) on the treatment of COVID-19 conducted across three centres in Egypt (Tanta University, Assiut University, Ain-shams University) on COVID-19 patients with similar inclusion criteria and overlapping time frames. Dr Sherief M Abd-Elsalam ran seven such RCTs across these three centres; four of these RCTs have since been retracted. We therefore set out to systematically analyse the integrity of all RCTs (co-)authored by Dr Abd-Elsalam, in particular 23 RCTs on Gastroenterology and Hepatology. Methods We searched PubMed, Google Scholar, Scopus and clinical trial registries for RCTs published by Dr Sherief M Abd-Elsalam, affiliated with the Department of Tropical Medicine and Infectious Diseases, Faculty of Medicine, Tanta University, Tanta, Egypt. We assessed trial registration, tables for identical data values, statistical errors, and improbable data trends. We assessed the probability of true randomization by assessing baseline characteristics through a Monte Carlo Analysis. Results We report on 30 published randomized control trials (RCTs) of Dr. Sherief Abd-Elsalam, in particular 23 RCTs on Gastroenterology and Hepatology. We found important issues in all RCTs examined. Of these 23 RCTs, 10 RCTs had substantial trial registration inconsistencies. Only one of these 10 RCTs has been retracted to date. We found nine RCTs with substantial statistical mistakes, five RCTs with similarities between tables unlikely to happen by chance, four RCTs with implausible Gaussian distributions, three RCTs in which almost all dichotomous variables had even values, while part of at least one study was plagiarized. Monte Carlo analysis indicated that the probability that distribution of baseline characteristics due to randomisation was 0.0000228. According to the trial registration, Dr. Abd-Elsalam is coordinating 76 clinical trials with 45 trials currently marked as ‘Recruiting’ and 17 trials marked as ‘Unknown Status’ as of November 2022. Interpretation We strongly recommend a thorough investigation of the data integrity of all RCTs by Dr Sherief M Abd-Elsalam by journal editors. Until the completion of such an investigation, we suggest that none of these studies are used to inform clinical practice.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://osf.io/vjcnp/" target="_blank">Concerns about data integrity of 30 randomized clinical trials from one author.</a>
</div></li>
<li><strong>The Your COVID-19 Risk Assessment Tool and the Accompanying Open Access Data and Materials Repositories</strong> -
<div>
In March 2020, the Your COVID-19 Risk tool was developed in response to the global spread of SARS-CoV-2. The tool is an online resource based on key behavioural evidence-based risk factors related to contracting and spreading SARS-CoV-2. This article describes the development of the tool, the produced resources, the associated open repository, and initial results. This tool was developed by a multidisciplinary research team consisting of more than 150 international experts. This project leverages knowledge obtained in behavioural science, aiming to promote behaviour change by assessing risk and supporting individuals completing the assessment tool to protect themselves and others from infection. To enable iterative improvements of the tool, tool users can optionally answer questions about behavioural determinants. The data and results are openly shared to support governments and health agencies developing behaviour change interventions. Over 60 000 users in more than 150 countries have assessed their risk and provided data.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://osf.io/b8n5g/" target="_blank">The Your COVID-19 Risk Assessment Tool and the Accompanying Open Access Data and Materials Repositories</a>
</div></li>
<li><strong>Anti-Viral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein Against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models</strong> -
<div>
Significance: SARS-CoV-2 Variants of Concern (VOCs) continue to evolve and re-emerge with chronic inflammatory long-COVID sequelae necessitating the development of anti-inflammatory therapeutic molecules. Therapeutic effects of the Receptor for Advanced Glycation End products (RAGE) were reported in many inflammatory diseases. However, a therapeutic effect of the RAGE in COVID-19 has not been reported. In the present study, we investigated whether and how the RAGE-Ig fusion protein would have an anti-viral and anti-inflammatory therapeutic effect in the COVID-19 system. Methods: The protective therapeutic effect of RAGE-Ig was determined in vitro in K18-hACE2 transgenic mice and Syrian golden hamsters infected with six various VOCs of SARS-CoV-2. The underlying anti-viral mechanism of RAGE-Ig was determined in vitro in SARS-CoV-2-infected human lung epithelial cells (BEAS-2B). Results: Following treatment of K18-hACE2 mice and hamsters infected with various SARS-CoV-2 VOCs with RAGE-Ig, we demonstrated: (i) significant dose-dependent protection (i.e. greater survival, less weight loss, lower virus replication in the lungs); (ii) a reduction of inflammatory macrophages (F4/80+/Ly6C+) and neutrophils (CD11b+/Ly6G+) infiltrating the infected lungs; (iii) a RAGE-Ig dose-dependent increase in the expression of type I interferons (IFN-alpha;, and IFN-beta) and type III interferon (IFN lambda2) and a decrease in the inflammatory cytokines (IL-6 and IL-8) in SARS-CoV-2-infected human lung epithelial cells; and (iv) a dose-dependent decrease in the expression of CD64 (FcgR1) on monocytes and lung epithelial cells from symptomatic COVID-19 patients. Conclusion: Our pre-clinical findings revealed type I and III interferons-mediated anti-viral and anti-inflammatory therapeutic effects of RAGE-Ig protein against COVID-19 caused by multiple SARS-CoV-2 VOCs.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2023.06.07.544133v1" target="_blank">Anti-Viral and Anti-Inflammatory Therapeutic Effect of RAGE-Ig Protein Against Multiple SARS-CoV-2 Variants of Concern Demonstrated in K18-hACE2 Mouse and Syrian Golden Hamster Models</a>
</div></li>
<li><strong>Potential for bias in (sero)prevalence estimates when not accounting for test sensitivity and specificity</strong> -
<div>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Objectives: The COVID-19 has led to many studies of seroprevalence. A number of methods exist in the statistical literature to correctly estimate disease prevalence in the presence of diagnostic test misclassification, but these methods seem to be less known and not routinely used in the public health literature. We aimed to show how widespread the problem is in recent publications, and to quantify the magnitude of bias introduced when correct methods are not used. Methods: We examined a sample of recent literature to determine how often public health researcher did not account for test performance in estimates of seroprevalence. Using straightforward calculations, we estimated the amount of bias introduced when reporting the proportion of positive test results instead of using sensitivity and specificity to estimate disease prevalence. Results: Of the seroprevalence studies sampled, 80% failed to account for sensitivity and specificity. Expected bias is often more than is desired in practice, ranging from 1% to 10%. Conclusions: Researchers conducting studies of prevalence should correctly account for test sensitivity and specificity in their statistical analysis.
</p>
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.medrxiv.org/content/10.1101/2022.11.24.22282720v6" target="_blank">Potential for bias in (sero)prevalence estimates when not accounting for test sensitivity and specificity</a>
</div></li>
<li><strong>COVFlow: performing virus phylodynamics analyses from selected SARS-CoV-2 genome sequences</strong> -
<div>
Phylodynamic analyses generate important and timely data to optimise public health response to SARS-CoV-2 outbreaks and epidemics. However, their implementation is hampered by the massive amount of sequence data and the difficulty to parameterise dedicated software packages. We introduce the COVFlow pipeline, accessible at https://gitlab.in2p3.fr/ete/CoV-flow, which allows a user to select sequences from the Global Initiative on Sharing Avian Influenza Data (GISAID) database according to user-specified criteria, to perform basic phylogenetic analyses, and to produce an XML file to be run in the Beast2 software package. We illustrate the potential of this tool by studying two sets of sequences from the Delta variant in two French regions. This pipeline can facilitate the use of virus sequence data at the local level, for instance, to track the dynamics of a particular lineage or variant in a region of interest.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2022.06.17.496544v5" target="_blank">COVFlow: performing virus phylodynamics analyses from selected SARS-CoV-2 genome sequences</a>
</div></li>
<li><strong>A Solution to the Kermack and McKendrick Integro-Differential Equations</strong> -
<div>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
In this manuscript, we derive a closed form solution to the full Kermack and McKendrick integro-differential equations (Kermack and McKendrick 1927) which we call the KMES. The KMES can be cast in the form of a step function response to the input of new infections; and that response is the time series of the total infections. We demonstrate the veracity of the KMES using independent data from the Covid 19 pandemic and derive many previously unknown and useful analytical expressions for diagnosing and managing an epidemic. These include new expressions for the viral load, the final size, the effective reproduction number, and the time to the peak in infections. Since the publication of the Kermack and McKendrick seminal paper (1927), thousands of authors have utilized the Susceptible, Infected, and Recovered (SIR) approximations; expressions which are putatively derived from the integro-differential equations, to model epidemic dynamics. Implicit in the use of the SIR approximation are the beliefs that there is no closed form solution to the more complex integro-differential equations, that the approximation adequately reproduces the dynamics of the integro-differential equations, and that herd immunity always exists. However, as we explicate in this manuscript, the KMES demonstrates that the SIR models are not adequate representations of the integro-differential equations, and herd immunity is not guaranteed. Our conclusion is that the KMES obsoletes the need for the SIR approximations; and provides a new level of understanding of epidemic dynamics.
</p>
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.medrxiv.org/content/10.1101/2022.04.28.22274442v3" target="_blank">A Solution to the Kermack and McKendrick Integro-Differential Equations</a>
</div></li>
<li><strong>Psychometric validation of the Portuguese Obsession with COVID-19 Scale (PT-OCS)</strong> -
<div>
The COVID-19 pandemic had relevant psychological effects on the Portuguese population, partially related to repetitive and disruptive thoughts about the disease. Successive lockdowns contributed to an additional burden on parents’ family-work-life balance. This study intends to validate the Portuguese version of the Obsession with COVID-19 Scale (OCS; Lee, 2020), drew upon a general sample from diverse country regions (n = 531) and a specific sample of Portuguese parents (n = 109). Confirmatory factor analysis’ results ensure the PT-OCS excellent psychometric properties both for the general sample [X2 (1) = 0.446, p = 0.504; CFI = 1.0; GFI = 1.0; RMSEA = 0.0; Standardized RMR = 0.003] and for the parents’ group [X2 (2) = 1.816, p = 0.403; CFI = 1.0; GFI = 0.99; RMSEA = 0.0; Standardized RMR = 0.016; p Bollen-Stine bootstrap = 0.65]. The scale had very good reliability results (0.84 &lt; α / ⍵ &lt; 0.88). As expected, obsession with COVID-19 was highly correlated with COVID-19 anxiety and women had higher PT-OCS scores. Findings suggest the PT-OCS as a reliable and valid measure to evaluate persistent and disruptive thinking about COVID-19, namely in different groups of the Portuguese population, with potentialities for future epidemic events.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://osf.io/whm8s/" target="_blank">Psychometric validation of the Portuguese Obsession with COVID-19 Scale (PT-OCS)</a>
</div></li>
<li><strong>Emotional distress and affective knowledge representation one year after the Covid-19 outbreak</strong> -
<div>
This study examines whether the detrimental effects of the COVID-19 pandemic on the affectivity of the population extend one year after the outbreak. In an online-mobile session, participants completed surveys (i.e. demographic characteristics, positive-negative affectivity, interoceptive awareness) and a similarity judgment task of triplets of emotional concepts, from which we derived 2D maps of their affective knowledge representation. Compared with pre-pandemic data derived from a comparable population, we report three main findings. First, we observed enhanced negative affectivity during the pandemic, but no changes in positive affectivity levels. Second, increased self-reported interoceptive awareness compared to pre-pandemic data, with greater attention to bodily sensations and adaptive aspects of interoceptive sensitivity. Furthermore, female participants reported higher scores than males on the questionnaire subscales of Emotional Awareness and Attention Regulation. Third, the effect of pandemic-related conditions is also apparent in the mental organization of emotional concepts, especially for female participants (i.e., reduced coherence in the organization of the concepts along the arousal dimension and more misclassification of concepts based on arousal) and participants who did not perform physical activity (a collapse of the arousal dimension). Some of the effects of the pandemic, thus, persist about a year after the outbreak. These results advise providing programs of psychological and emotional assistance throughout the pandemic beyond the outbreak, and that age-dependent gender differences should be accounted for to define tailored interventions. Physical activity might relieve pandemic-related stressors, so it should be promoted during particularly stressful periods for the population.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://osf.io/gmazn/" target="_blank">Emotional distress and affective knowledge representation one year after the Covid-19 outbreak</a>
</div></li>
<li><strong>Towards Pandemic-Scale Ancestral Recombination Graphs of SARS-CoV-2</strong> -
<div>
Recombination is an ongoing and increasingly important feature of circulating lineages of SARS-CoV-2, challenging how we represent the evolutionary history of this virus and giving rise to new variants of potential public health concern by combining transmission and immune evasion properties of different lineages. Detection of new recombinant strains is challenging, with most methods looking for breaks between sets of mutations that characterise distinct lineages. In addition, many basic approaches fundamental to the study of viral evolution assume that recombination is negligible, in that a single phylogenetic tree can represent the genetic ancestry of the circulating strains. Here we present an initial version of sc2ts, a method to automatically detect recombinants in real time and to cohesively integrate them into a genealogy in the form of an ancestral recombination graph (ARG), which jointly records mutation, recombination and genetic inheritance. We infer two ARGs under different sampling strategies, and study their properties. One contains 1.27 million sequences sampled up to June 30, 2021, and the second is more sparsely sampled, consisting of 657K sequences sampled up to June 30, 2022. We find that both ARGs are highly consistent with known features of SARS-CoV-2 evolution, recovering the basic backbone phylogeny, mutational spectra, and recapitulating details on the majority of known recombinant lineages. Using the well-established and feature-rich tskit library, the ARGs can also be stored concisely and processed efficiently using standard Python tools. For example, the ARG for 1.27 million sequences—encoding the inferred reticulate ancestry, genetic variation, and extensive metadata—requires 58MB of storage, and loads in less than a second. The ability to fully integrate the effects of recombination into downstream analyses, to quickly and automatically detect new recombinants, and to utilise an efficient and convenient platform for computation based on well-engineered technologies makes sc2ts a promising approach.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2023.06.08.544212v1" target="_blank">Towards Pandemic-Scale Ancestral Recombination Graphs of SARS-CoV-2</a>
</div></li>
<li><strong>Single-cell RNA sequencing reveals HIF1A as a severity-sensitive immunological scar in circulating monocytes of convalescent comorbidity-free COVID-19 patients</strong> -
<div>
COVID-19, caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), is characterized by a wide range of clinical symptoms and a poorly predictable disease course. Although in-depth transcriptomic investigations of peripheral blood samples from COVID-19 patients have been performed, the detailed molecular mechanisms underlying an asymptomatic, mild or severe disease course, particularly in patients without relevant comorbidities, remain poorly understood. While previous studies have mainly focused on the cellular and molecular dissection of ongoing COVID-19, we set out to characterize transcriptomic immune cell dysregulation at the single-cell level at different time points in patients without comorbidities after disease resolution to identify signatures of different disease severities in convalescence. With single-cell RNA sequencing we reveal a role for hypoxia-inducible factor 1-alpha (HIF1A) as a severity-sensitive long-term immunological scar in circulating monocytes of convalescent COVID-19 patients. Additionally, circulating complexes formed by monocytes with either T cells or NK cells represent a characteristic cellular marker in convalescent COVID-19 patients irrespective of their preceding symptom severity. Together, these results provide cellular and molecular correlates of recovery from COVID-19 and could help in immune monitoring and in the design of new treatment strategies.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2023.06.07.544062v1" target="_blank">Single-cell RNA sequencing reveals HIF1A as a severity-sensitive immunological scar in circulating monocytes of convalescent comorbidity-free COVID-19 patients</a>
</div></li>
<li><strong>An evolutionarily conserved strategy for ribosome binding and inhibition by β-coronavirus non-structural protein 1</strong> -
<div>
An important pathogenicity factor of SARS-CoV-2 and related coronaviruses is Nsp1, which suppresses host gene expression and stunts antiviral signaling. SARS-CoV-2 Nsp1 binds the ribosome to inhibit translation through mRNA displacement and induces degradation of host mRNAs through an unknown mechanism. Here we show that Nsp1-dependent host shutoff is conserved in diverse coronaviruses, but only Nsp1 from beta-CoV inhibits translation through ribosome binding. The C-terminal domain of all beta-CoV Nsp1s confers high-affinity ribosome-binding despite low sequence conservation. Modeling of interactions of four Nsp1s to the ribosome identified few absolutely conserved amino acids that, together with an overall conservation in surface charge, form the beta-CoV Nsp1 ribosome-binding domain. Contrary to previous models, the Nsp1 ribosome-binding domain is an inefficient translation inhibitor. Instead, the Nsp1-CTD likely functions by recruiting Nsp1's N-terminal effector domain. Finally, we show that a viral cis-acting RNA element has co-evolved to fine-tune SARS-CoV-2 Nsp1 function, but does not provide similar protection against Nsp1 from related viruses. Together, our work provides new insight into the diversity and conservation of ribosome-dependent host-shutoff functions of Nsp1, knowledge that could aide future efforts in pharmacological targeting of Nsp1 from SARS-CoV-2, but also related human-pathogenic beta-coronaviruses. Our study also exemplifies how comparing highly divergent Nsp1 variants can help to dissect the different modalities of this multi-functional viral protein.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2023.06.07.544141v1" target="_blank">An evolutionarily conserved strategy for ribosome binding and inhibition by β-coronavirus non-structural protein 1</a>
</div></li>
<li><strong>Re-annotation of SARS-CoV-2 proteins using an HHpred-based approach opens new opportunities for a better understanding of this virus</strong> -
<div>
Since the publication of the genome of SARS-CoV-2, the causative agent of COVID-19, in January 2020, many bioinformatic tools have been applied to annotate its proteins. Although effcient methods have been used, such as the identification of protein domains stored in Pfam, most of the proteins of this virus have no detectable homologous protein domains outside the viral taxa. As it is now well established that some viral proteins share similarities with proteins of their hosts, we decided to explore the hypothesis that this lack of homologies could be, at least in part, the result of the documented loss of sensitivity of Pfam Hidden Markov Models (HMMs) when searching for domains in "divergent organisms". In order to improve the annotation of SARS-CoV-2 proteins, we used the HHpred protein annotation tool. To avoid "false positive predictions" as much as possible, we designed a robustness procedure to evaluate the HHpred results. In total, 6 robust similarities involving 6 distinct SARS-CoV-2 proteins were detected. Of these 6 similarities, 3 are already known and well documented, and one is in agreement with recent crystallographic results. We then examined carefully the two similarities that have not yet been reported in the literature. We first show that the C-terminal part of Spike S (the protein that binds the virion to the cell membrane by interacting with the host receptor, triggering infection) has similarities with the human prominin-1/CD133; after reviewing what is known about prominin-1/CD133, we suggest that the C-terminal part of Spike S could both improve the docking of Spike S to ACE2 (the main cell entry receptor for SARS-CoV-2) and be involved in the delivery of virions to regions where ACE2 is located in cells. Secondly, we show that the SARS-CoV-2 ORF3a protein shares similarities with human G protein-coupled receptors (GPCRs) belonging mainly to the "Rhodopsin family"; on the basis of the literature, we then show that specific G protein-coupled receptors (GPCRs) of this family are known to form ion channels; we emphasize this is consistent with a recent Cryo-EM structure of SARS-CoV-2 ORF3a suggesting that it can form a non-selective Ca2+-permeable cation channel; furthermore, we highlight that some of the GPCRs identified as sharing similarities with ORF3a are targeted by antibodies in patients with COVID-19 and Long-COVID, suggesting that these similarities may trigger some of the observed autoimmune responses. We conclude that the approach described here (or similar approaches) opens up new avenues of research to better understand SARS-CoV-2 and could be used to complement virus annotations, particularly for less-studied viruses.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2023.06.06.543855v1" target="_blank">Re-annotation of SARS-CoV-2 proteins using an HHpred-based approach opens new opportunities for a better understanding of this virus</a>
</div></li>
<li><strong>Independent regulation of Z-lines and M-lines during sarcomere assembly in cardiac myocytes revealed by the automatic image analysis software sarcApp</strong> -
<div>
Sarcomeres are the basic contractile units within cardiac myocytes, and the collective shortening of sarcomeres aligned along myofibrils generates the force driving the heartbeat. The alignment of the individual sarcomeres is important for proper force generation, and misaligned sarcomeres are associated with diseases including cardiomyopathies and COVID-19. The actin bundling protein, -actinin-2, localizes to the Z-Bodies of sarcomere precursors and the Z-Lines of sarcomeres, and has been used previously to assess sarcomere assembly and maintenance. Previous measurements of -actinin-2 organization have been largely accomplished manually, which is time-consuming and has hampered research progress. Here, we introduce sarcApp, an image analysis tool that quantifies several components of the cardiac sarcomere and their alignment in muscle cells and tissue. We first developed sarcApp to utilize deep learning- based segmentation and real space quantification to measure -actinin-2 structures and determine the organization of both precursors and sarcomeres/myofibrils. We then expanded sarcApp to analyze M-Lines using the localization of myomesin and a protein that connects the Z-Lines to the M-Line (titin). sarcApp produces 33 distinct measurements per cell and 24 per myofibril that allow for precise quantification of changes in sarcomeres, myofibrils, and their precursors. We validated this system with perturbations to sarcomere assembly. Surprisingly, we found perturbations that affected Z-Lines and M-Lines differently, suggesting that they may be regulated independently during sarcomere assembly.
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.biorxiv.org/content/10.1101/2023.01.11.523681v2" target="_blank">Independent regulation of Z-lines and M-lines during sarcomere assembly in cardiac myocytes revealed by the automatic image analysis software sarcApp</a>
</div></li>
<li><strong>Estimating the effectiveness of COVID-19 vaccination against COVID-19 hospitalisation and death: a cohort study based on the 2021 Census, England.</strong> -
<div>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Objective: To estimate the effectiveness of COVID-19 vaccination against hospitalisation for COVID-19 and death involving COVID-19 in England using linked population level data sources including the 2021 Census. Design: Retrospective cohort study. Setting: England, 21 March 2021 to 20 March 2022. Participants: Individuals alive and aged 16+ on 21 March 2021, resident in England, enumerated in the 2021 Census as a usual resident, and able to link to an NHS number. A sample of 583,840 individuals was used for the analysis. Exposures: COVID-19 vaccination: first dose, second dose and third dose/first booster dose, with categories for time since each dose. Main outcome measures: Hospitalisation for COVID-19 or death involving COVID-19. An adjusted Cox proportional hazard model was used to estimate the hazard ratio for the outcomes for vaccinated participants for different doses and time since dose compared to unvaccinated individuals. Vaccine effectiveness was estimated as (1 minus hazard ratio)x 100%. A control outcome of non-COVID-19 death was also assessed. Results: Vaccine effectiveness against hospitalisation for COVID-19 was 52.1% (95% confidence interval 51.3% to 52.8%) for a first dose, 55.6% (55.2% to 56.1%) for a second dose and 77.6% (77.3% to 78.0%) for a third dose, with a decrease in vaccine effectiveness 3+ months after the third dose. Vaccine effectiveness against COVID-19 mortality was 58.7% (52.7% to 63.9%) for a first dose, 88.5% (87.5% to 89.5%) for a second dose and 93.2% (92.9% to 93.5%) for a third dose, with evidence of waning 3+ months after the second and third doses. For the second dose, which is the most comparable across the different time-periods, vaccine effectiveness was higher against COVID-19 hospitalisation but slightly lower against COVID-19 mortality in the Omicron dominant period than the period before the Omicron variant became dominant. Vaccine effectiveness against both COVID-19 hospitalisation and mortality was higher in general for mRNA vaccines than non mRNA vaccines, however this could be influenced by the different populations given each vaccine vector. Non-zero VE against non-COVID-19 mortality indicates that residual confounding may impact the results, despite the inclusion of up-to-date socio-demographic adjustments and various sources of health data, with possible frailty bias, confounding by indication and a healthy vaccinee effect observed. Conclusions: The vaccine effectiveness estimates show increased protection with number of doses and a high level of protection against both COVID-19 hospitalisation and mortality for the third/booster dose, as would be expected from previous research. However, despite the various sources of health data used to adjust the models, the estimates for different breakdowns and for non-COVID-19 mortality expose residual confounding by health status, which should be considered when interpreting estimates of vaccine effectiveness.
</p>
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.medrxiv.org/content/10.1101/2023.06.06.23290982v1" target="_blank">Estimating the effectiveness of COVID-19 vaccination against COVID-19 hospitalisation and death: a cohort study based on the 2021 Census, England.</a>
</div></li>
<li><strong>Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study</strong> -
<div>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Background: Although CoronaVac was the only Covid-19 vaccine adopted in the first months of the Brazilian vaccination campaign, randomized clinical trials to evaluate its efficacy in elderly adults were limited. In this study, we use routinely collected surveillance and SARS-CoV-2 vaccination and testing data comprising the population of the fifth largest city of Brazil to evaluate the effectiveness of CoronaVac in adults 60+ years old against severe outcomes. Methods: Using large observational databases on vaccination and surveillance data from the city of Fortaleza, Brazil, we defined a retrospective cohort including 324,302 eligible adults aged ≥ 60 years to evaluate the effectiveness of the CoronaVac vaccine. The cohort included individuals vaccinated between January 21, 2021, and August 31, 2021, who were matched with unvaccinated persons at the time of rollout following a 1:1 ratio according to baseline covariates of age, sex, and Human Development Index of the neighborhood of residence. Only Covid-19-related severe outcomes were included in the analysis: hospitalization, ICU admission, and death. Vaccine effectiveness for each outcome was calculated by using the risk ratio between the two groups, with the risk obtained by the Kaplan-Meier estimator. Results: We obtained 62,643 matched pairs for assessing the effectiveness of the two-dose regimen of CoronaVac. The demographic profile of the matched population was statistically representative of the population of Fortaleza. Using the cumulative incidence as the risk associated with each group, starting at day 14 since the receipt of the second dose, we found an 82.3% (95% CI 66.3 - 93.9) effectiveness against Covid-19-related death, 68.4% (95% CI 42.3 - 86.4) against ICU admission, and 55.8% (95% CI 42.7 - 68.3) against hospital admission. Conclusions: Our results show that, despite critical delays in vaccine delivery and limited evidence in efficacy trial estimates, CoronaVac contributed to preventing deaths and severe morbidity due to Covid-19 in elderly adults.
</p>
</div>
<div class="article-link article-html-link">
🖺 Full Text HTML: <a href="https://www.medrxiv.org/content/10.1101/2023.06.06.23291015v1" target="_blank">Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study</a>
</div></li>
</ul>
<h1 data-aos="fade-right" id="from-clinical-trials">From Clinical Trials</h1>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Extracorporeal Photopheresis as a Possible Therapeutic Approach to Adults With Severe and Critical COVID-19</strong> - <b>Condition</b>:   COVID-19<br/><b>Intervention</b>:   Procedure: Extracorporeal photopheresis<br/><b>Sponsor</b>:   Del-Pest Central Hospital - National Institute of Hematology and Infectious Diseases<br/><b>Recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>A Clinical Trial on Booster Immunization of Two COVID-19 Vaccines Constructed From Different Technical Routes</strong> - <b>Condition</b>:   COVID-19<br/><b>Interventions</b>:   Biological: Prototype and Omicron BA.4/5 Bivalent Recombinant COVID-19 Vaccine(Adenovirus Type 5 Vector) For Inhalation;   Biological: Bivalent COVID-19 mRNA Vaccine;   Biological: Recombinant COVID-19 Vaccine (Adenovirus Type 5 Vector) For Inhalation<br/><b>Sponsors</b>:   Zhongnan Hospital;   Institute of Biotechnology, Academy of Military Medical Sciences, PLA of China<br/><b>Recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Community-engaged Optimization of COVID-19 Rapid Evaluation And TEsting Experiences</strong> - <b>Conditions</b>:   COVID-19;   COVID-19 Pandemic<br/><b>Interventions</b>:   Behavioral: COVID-19 walk-up, on-site testing strategy;   Behavioral: Community Health Worker (CHW) leading testing navigation and general preventive care reminders;   Behavioral: No-cost self-testing kit vending machines<br/><b>Sponsors</b>:   University of California, San Diego;   San Ysidro Health Center<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>ACTIV-6: COVID-19 Study of Repurposed Medications - Arm F (Montelukast)</strong> - <b>Condition</b>:   Covid19<br/><b>Interventions</b>:   Other: Placebo;   Drug: Montelukast<br/><b>Sponsors</b>:   Susanna Naggie, MD;   National Center for Advancing Translational Sciences (NCATS);   Vanderbilt University Medical Center<br/><b>Recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>ACTIV-6: COVID-19 Study of Repurposed Medications - Arm B (Fluvoxamine)</strong> - <b>Condition</b>:   Covid19<br/><b>Interventions</b>:   Drug: Fluvoxamine;   Other: Placebo<br/><b>Sponsors</b>:   Susanna Naggie, MD;   National Center for Advancing Translational Sciences (NCATS);   Vanderbilt University Medical Center<br/><b>Completed</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>ACTIV-6: COVID-19 Study of Repurposed Medications - Arm D (Ivermectin 600)</strong> - <b>Condition</b>:   Covid19<br/><b>Interventions</b>:   Drug: Ivermectin;   Other: Placebo<br/><b>Sponsors</b>:   Susanna Naggie, MD;   National Center for Advancing Translational Sciences (NCATS);   Vanderbilt University Medical Center<br/><b>Completed</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>ACTIV-6: COVID-19 Study of Repurposed Medications - Arm E (Fluvoxamine 100)</strong> - <b>Condition</b>:   Covid19<br/><b>Interventions</b>:   Drug: Fluvoxamine;   Other: Placebo<br/><b>Sponsors</b>:   Susanna Naggie, MD;   National Center for Advancing Translational Sciences (NCATS);   Vanderbilt University Medical Center<br/><b>Completed</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Safety Study of COVID19 Vaccine on the Market</strong> - <b>Condition</b>:   COVID-19<br/><b>Intervention</b>:   Biological: Recombinant new coronavirus vaccine (CHO cell)<br/><b>Sponsors</b>:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.;   Hunan Provincial Center for Disease Control and Prevention;   Guizhou Center for Disease Control and Prevention;   Hainan Center for Disease Control &amp; Prevention<br/><b>Recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Evaluation of Home Use COVID-19 Frequent Antigen Testing and Data Reporting</strong> - <b>Condition</b>:   COVID-19 Respiratory Infection<br/><b>Intervention</b>:   Diagnostic Test: SARS CoV-2 antigen tests<br/><b>Sponsors</b>:   IDX20 Inc;   National Institute on Minority Health and Health Disparities (NIMHD)<br/><b>Recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Pycnogenol® in Post-COVID-19 Condition</strong> - <b>Conditions</b>:   Post COVID-19 Condition;   Long COVID<br/><b>Interventions</b>:   Drug: Pycnogenol®;   Drug: Placebo<br/><b>Sponsor</b>:   University of Zurich<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Efficacy of Bailing Capsule on Pulmonary Fibrosis After COVID-19</strong> - <b>Conditions</b>:   Pulmonary Fibrosis;   COVID-19 Pneumonia<br/><b>Intervention</b>:   Drug: Bailing capsule<br/><b>Sponsor</b>:   Second Affiliated Hospital, School of Medicine, Zhejiang University<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Mitoquinone/Mitoquinol Mesylate as Oral and Safe Postexposure Prophylaxis for Covid-19</strong> - <b>Conditions</b>:   SARS-CoV Infection;   COVID-19<br/><b>Interventions</b>:   Drug: Mitoquinone/mitoquinol mesylate;   Other: Placebo<br/><b>Sponsor</b>:   University of Texas Southwestern Medical Center<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Evaluating Emetine for Viral Outbreaks (EVOLVE)</strong> - <b>Condition</b>:   COVID-19<br/><b>Interventions</b>:   Drug: Emetine Hydrochloride;   Drug: Placebo<br/><b>Sponsors</b>:   Johns Hopkins University;   Nepal Health Research Council;   Bharatpur Hospital Chitwan;   Stony Brook University;   Rutgers University<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Anti-SARS-CoV-2 Monoclonal Antibodies for Long COVID (COVID-19)</strong> - <b>Conditions</b>:   Long COVID;   Post-Acute Sequela of COVID-19;   Post-Acute COVID-19<br/><b>Interventions</b>:   Drug: AER002;   Other: Placebo<br/><b>Sponsors</b>:   Michael Peluso, MD;   Aerium Therapeutics<br/><b>Not yet recruiting</b></p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>To Evaluate the Immunogenicity and Safety of Sequential Booster Immunization of Recombinant Novel Coronavirus Vaccine (CHO Cells) for SARS-CoV-2</strong> - <b>Condition</b>:   COVID-19<br/><b>Intervention</b>:   Biological: Recombinant Novel Coronavirus vaccine (CHO Cells)<br/><b>Sponsor</b>:   Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.<br/><b>Completed</b></p></li>
</ul>
<h1 data-aos="fade-right" id="from-pubmed">From PubMed</h1>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Serum proteomics hint at an early T-cell response and modulation of SARS-CoV-2-related pathogenic pathways in COVID-19-ARDS treated with Ruxolitinib</strong> - CONCLUSION: Our results indicate that the mechanism of action of Ruxo in COVID-19-ARDS can be related to both known effects of this drug as a modulator of T-cells and the SARS-CoV-2-infection.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Elucidation of novel compounds and epitope-based peptide vaccine design against C30 endopeptidase regions of SARS-CoV-2 using immunoinformatics approaches</strong> - There has been progressive improvement in immunoinformatics approaches for epitope-based peptide design. Computational-based immune-informatics approaches were applied to identify the epitopes of SARS-CoV-2 to develop vaccines. The accessibility of the SARS-CoV-2 protein surface was analyzed, and hexa-peptide sequences (KTPKYK) were observed having a maximum score of 8.254, located between amino acids 97 and 102, whereas the FSVLAC at amino acids 112 to 117 showed the lowest score of 0.114. The…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Host microRNA interactions with the SARS-CoV-2 viral genome 3’-untranslated region</strong> - The 2019 pandemic, caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has marked the spread of a novel human coronavirus. While the viral life cycle is well understood, most of the interactions at the virus-host interface remain elusive. Furthermore, the molecular mechanisms behind disease severity and immune evasion are still largely unknown. Conserved elements of the viral genome such as secondary structures within the 5’- and 3’-untranslated regions (UTRs) serve as…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Vascular Endothelial-derived SPARCL1 Exacerbates Viral Pneumonia Through Pro-Inflammatory Macrophage Activation</strong> - Inflammation upon infectious lung injury is a double-edged sword: while tissue-infiltrating immune cells and cytokines are necessary to control infection, these same factors often aggravate injury. Full appreciation of both the sources and targets of inflammatory mediators is required to facilitate strategies to maintain antimicrobial effects while minimizing off-target epithelial and endothelial damage. Recognizing that the vasculature is centrally involved in tissue responses to injury and…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong><em>In vitro</em> reconstitution of SARS CoV-2 Nsp1-induced mRNA cleavage reveals the key roles of the N-terminal domain of Nsp1 and the RRM domain of eIF3g</strong> - SARS CoV-2 nonstructural protein 1 (Nsp1) is the major pathogenesis factor that inhibits host translation using a dual strategy of impairing initiation and inducing endonucleolytic cleavage of cellular mRNAs. To investigate the mechanism of cleavage, we reconstituted it in vitro on β-globin, EMCV IRES and CrPV IRES mRNAs that use unrelated initiation mechanisms. In all instances, cleavage required Nsp1 and only canonical translational components (40S subunits and initiation factors), arguing…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>A Novel Viral Assembly Inhibitor Blocks SARS-CoV-2 Replication in Airway Epithelial Cells</strong> - The ongoing evolution of SARS-CoV-2 to evade vaccines and therapeutics underlines the need for novel therapies with high genetic barriers to resistance. The small molecule PAV-104, identified through a cell-free protein synthesis and assembly screen, was recently shown to target host protein assembly machinery in a manner specific to viral assembly. Here, we investigated the capacity of PAV-104 to inhibit SARS-CoV-2 replication in human airway epithelial cells (AECs). Our data demonstrate that…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Virtual Health Promotion Work-Integrated Learning Placements: A COVID-19 Consequence or Preparation for the Future?</strong> - We explored student and industry supervisors’ experiences of virtual work-integrated learning (vWIL) health promotion placements during the COVID-19 pandemic. Using a descriptive phenomenological qualitative methodology, we conducted semi-structured interviews with eight students and eight supervisors of undergraduate health promotion-related placements at community, not-for-profit and government organizations. We asked participants about the aspects of their placement they found most enjoyable…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Designing for digital transformation of residency education - a post-pandemic pedagogical response</strong> - CONCLUSIONS: The study reflects the course leaders’ pedagogical response to the pandemic, as remote teaching became the only way to provide residency education. Initially, the sudden shift was perceived as constraining, but over time they found new affordances through the enforced use of digital technology that helped them not only to cope with the transition but also to innovate their pedagogical methods. After a rapid, forced shift from on-site to digital courses, it is crucial to utilize…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Eco-friendly and effective antimicrobial Melaleuca alternifolia essential oil Pickering emulsions stabilized with cellulose nanofibrils against bacteria and SARS-CoV-2</strong> - Melaleuca alternifolia essential oil (MaEO) is a green antimicrobial agent suitable for confection eco-friendly disinfectants to substitute conventional chemical disinfectants commonly formulated with toxic substances that cause dangerous environmental impacts. In this contribution, MaEO-in-water Pickering emulsions were successfully stabilized with cellulose nanofibrils (CNFs) by a simple mixing procedure. MaEO and the emulsions presented antimicrobial activities against Staphylococcus aureus…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Porcine Deltacoronavirus Infection Disrupts the Intestinal Mucosal Barrier and Inhibits Intestinal Stem Cell Differentiation to Goblet Cells via the Notch Signaling Pathway</strong> - Goblet cells and their secreted mucus are important elements of the intestinal mucosal barrier, which allows host cells to resist invasion by intestinal pathogens. Porcine deltacoronavirus (PDCoV) is an emerging swine enteric virus that causes severe diarrhea in pigs and causes large economic losses to pork producers worldwide. To date, the molecular mechanisms by which PDCoV regulates the function and differentiation of goblet cells and disrupts the intestinal mucosal barrier remain to be…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>SARS-CoV-2 infection impairs NK cell functions <em>via</em> activation of the LLT1-CD161 axis</strong> - CONCLUSION: We propose a novel mechanism of SARS-CoV-2 inhibition of NK cell functions via activation of the LLT1-CD161 axis.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature</strong> - DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect. Here, the authors have presented a brief appraisal of DPP-4 inhibitors, their modes of action, and the clinical efficiency of currently available drugs based on DPP-4 inhibitors. The safety profiles as well as future directions including their potential application in improving COVID-19 patient outcomes have also been discussed in detail. This review also…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Failure of TRPC6 inhibition to prevent COVID-19 deterioration: more questions than answers</strong> - No abstract</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>The CH24H metabolite, 24HC, blocks viral entry by disrupting intracellular cholesterol homeostasis</strong> - Cholesterol-24-hydroxylase (CH24H or Cyp46a1) is a reticulum-associated membrane protein that plays an irreplaceable role in cholesterol metabolism in the brain and has been well-studied in several neuro-associated diseases in recent years. In the present study, we found that CH24H expression can be induced by several neuroinvasive viruses, including vesicular stomatitis virus (VSV), rabies virus (RABV), Semliki Forest virus (SFV) and murine hepatitis virus (MHV). The CH24H metabolite,…</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Novel Fluorescent Benzothiazolyl-Coumarin Hybrids as Anti-SARS-COVID-2 Agents Supported by Molecular Docking Studies: Design, Synthesis, X-ray Crystal Structures, DFT, and TD-DFT/PCM Calculations</strong> - This study revealed the design and preparation of new 3-(benzo[d]thiazol-2-yl)-2H-chromen-2-one derivatives 9a-h. The structures of the synthesized products were elucidated by their spectroscopic data and X-ray crystallography for compounds 9a and 9d. The prepared new compounds were measured for their fluorescence, and a good result indicated that the emission efficiency was decreased by increasing the electron-withdrawing groups from the unsubstituted compound 9a to the highly substituted…</p></li>
</ul>
<h1 data-aos="fade-right" id="from-patent-search">From Patent Search</h1>
<script>AOS.init();</script></body></html>

441
archive-daily-dose/09 June, 2023.html Normal file
View File

@ -0,0 +1,441 @@
<!DOCTYPE html>
<html lang="" xml:lang="" xmlns="http://www.w3.org/1999/xhtml"><head>
<meta charset="utf-8"/>
<meta content="pandoc" name="generator"/>
<meta content="width=device-width, initial-scale=1.0, user-scalable=yes" name="viewport"/>
<title>09 June, 2023</title>
<style>
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>
<title>Daily-Dose</title><meta content="width=device-width, initial-scale=1.0" name="viewport"/><link href="styles/simple.css" rel="stylesheet"/><link href="../styles/simple.css" rel="stylesheet"/><style>*{overflow-x:hidden;}</style><link href="https://unpkg.com/aos@2.3.1/dist/aos.css" rel="stylesheet"/><script src="https://unpkg.com/aos@2.3.1/dist/aos.js"></script></head>
<body>
<h1 data-aos="fade-down" id="daily-dose">Daily-Dose</h1>
<h1 data-aos="fade-right" data-aos-anchor-placement="top-bottom" id="contents">Contents</h1>
<ul>
<li><a href="#from-new-yorker">From New Yorker</a></li>
<li><a href="#from-vox">From Vox</a></li>
<li><a href="#from-the-hindu-sports">From The Hindu: Sports</a></li>
<li><a href="#from-the-hindu-national-news">From The Hindu: National News</a></li>
<li><a href="#from-bbc-europe">From BBC: Europe</a></li>
<li><a href="#from-ars-technica">From Ars Technica</a></li>
<li><a href="#from-jokes-subreddit">From Jokes Subreddit</a></li>
</ul>
<h1 data-aos="fade-right" id="from-new-yorker">From New Yorker</h1>
<ul>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>The Supreme Court’s Damper on the Right to Strike</strong> - In a near-unanimous opinion, the Justices made it easier for employers to sue labor unions for damages caused by a work stoppage. - <a href="https://www.newyorker.com/news/daily-comment/the-supreme-courts-damper-on-the-right-to-strike">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>The Day That Wildfire Smoke Shrouded New York City</strong> - As the world warms and Canada burns, what once seemed unprecedented is becoming familiar. - <a href="https://www.newyorker.com/news/our-local-correspondents/trying-to-breathe-in-a-city-of-smoke">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>What the Shakeup at CNN Says About the Future of Cable News</strong> - Will Chris Licht’s attempts to move the network toward the center outlast his own brief tenure as C.E.O.? - <a href="https://www.newyorker.com/news/annals-of-communications/what-the-shakeup-at-cnn-says-about-the-future-of-cable-news">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Tucker Carlson Is Sort of Back</strong> - The former Fox host is embracing his new outsider status with “Tucker on Twitter.” - <a href="https://www.newyorker.com/news/our-columnists/tucker-carlson-is-sort-of-back">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Finally, a Few G.O.P. Candidates Dare to Speak Trump’s Name</strong> - The former President has been indicted again—but does it matter? - <a href="https://www.newyorker.com/news/letter-from-bidens-washington/finally-a-few-gop-candidates-dare-to-speak-trumps-name">link</a></p></li>
</ul>
<h1 data-aos="fade-right" id="from-vox">From Vox</h1>
<ul>
<li><strong>Wildfire smoke reminded people about climate change. How soon will they forget?</strong> -
<figure>
<img alt="People wear face masks on June 7, 2023, walking down a street in New York City, their surroundings hazed in orange by smoke from Canadian wildfires." src="https://cdn.vox-cdn.com/thumbor/AmnTYvTCQ1KZRtd75TwZdjnyvoo=/340x0:3451x2333/1310x983/cdn.vox-cdn.com/uploads/chorus_image/image/72354725/GettyImages_1258526774.0.jpeg"/>
<figcaption>
Smoke from Canadian wildfires renewed attention on climate change, but the effect may not last. | Lev Radin/Anadolu Agency via Getty Images
</figcaption>
</figure>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Extreme weather and climate-linked disasters don’t always lead to changes in public opinion.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="FIAREa">
The <a href="https://www.vox.com/science/2023/6/7/23752832/canada-fires-smoke-climate-change">smoke cloud over the East Coast</a> from <a href="https://www.vox.com/climate/2023/6/8/23753980/canada-fires-smoke-climate-change-air-quality">record wildfires in Canada</a> has become an impossible-to-ignore story. Turn on the news or log into any form of social media this week, and you’ll soon hear reports of increasingly toxic air or see otherworldly photos of orange skies over metropolises like New York and Washington, DC.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="caNo2J">
Or if you’re anywhere along the eastern seaboard, a brief whiff of air outside may be enough to learn what it’s like to breathe some of the worst pollution in the world.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ooHGlh">
Given that the smoke has shrouded one of the most populated parts of the country (and some of the largest media markets), it makes sense that the dirty air is getting a lot of attention. And many people under the pall are drawing a link to rising average temperatures. President Joe Biden on Thursday called it “<a href="https://twitter.com/potus/status/1666889078531403776">another stark reminder of the impacts of climate change</a>.”
</p>
<div id="y95y5i">
<blockquote class="twitter-tweet">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" dir="ltr" lang="en">
Due to hundreds of uncontrolled wildfires across Canada, New York City looks like a post-apocalyptic hellscape.<br/><br/>If you want a prelude of what the world is going to look like if we do not address man-made climate change — this is it. <a href="https://twitter.com/hashtag/ActOnClimate?src=hash&amp;ref_src=twsrc%5Etfw">#ActOnClimate</a> <a href="https://t.co/cimHQkDwkZ">pic.twitter.com/cimHQkDwkZ</a>
</p>
— Mike Hudema (<span class="citation" data-cites="MikeHudema">@MikeHudema</span>) <a href="https://twitter.com/MikeHudema/status/1666515598057021467?ref_src=twsrc%5Etfw">June 7, 2023</a>
</blockquote></div></li>
</ul>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="kwXyBK">
But after the fires burn out and the smoke dissipates, will people still care as much about rising temperatures? And will that concern translate into action? To an extent, sure. But public opinion research on this is surprisingly murky.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="lezRTJ">
“Overall, Americans are growing more concerned about climate change,” said <a href="https://communication.gmu.edu/people/emaibach">Edward Maibach</a>, director of the Center for Climate Change Communication at George Mason University, in an email. “The increasing frequency of extreme weather events and wildfires is likely playing a role in this growing rate of concern.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="2dZqQ0">
It’s important to note that wildfires are a regular, natural phenomenon in many forests, including those in Canada. But several factors converged to make the recent blazes so stunning. Eastern Canadian forests experienced abnormally high temperatures and low humidity this year. Swirling winds above Nova Scotia then pushed the rising smoke south along the Atlantic coast toward New York City and then Philadelphia, Baltimore, and Washington, DC, places that don’t typically get this kind of smoke.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="Lv6SBl">
However, rising average temperatures are increasing the chances of fomenting the conditions for large fires as well. “As the atmosphere warms, the ability to suck moisture out of the fuel [trees and other vegetation] increases almost exponentially,” Mike Flannigan, a wildland fire professor at the University of Alberta, told <a href="https://www.vox.com/science/2023/6/7/23752832/canada-fires-smoke-climate-change">Vox’s Benji Jones</a>. Which is to say, climate change didn’t “cause” these fires, but it’s a factor that’s driving up the overall risk of major infernos. Growing populations in vulnerable areas also mean that more people and property are afflicted when fires do ignite.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="bL38HB">
Recent polls have shown that Americans are connecting these dots. The <a href="https://www.pewresearch.org/short-reads/2022/08/12/most-americans-who-have-faced-extreme-weather-see-a-link-to-climate-change-republicans-included/">Pew Research Center reported last year</a> that among people who experienced events like heat waves, drought, and wildfires, more than 80 percent said climate change played a role. However, there was a big gap between Republicans and Democrats, with Democrats more likely to report a larger role for climate change.
</p>
<figure class="e-image">
<img alt="Chart showing how people perceive the role of climate change in various extreme weather events." src="https://cdn.vox-cdn.com/thumbor/VQ4zo8X9gazhFxbJoH-iI15xZfo=/800x0/filters:no_upscale()/cdn.vox-cdn.com/uploads/chorus_asset/file/24712597/FT_22.08.10_ExtremeWeather_02__1_.jpg"/> <cite><a class="ql-link" href="https://www.pewresearch.org/short-reads/2022/08/12/most-americans-who-have-faced-extreme-weather-see-a-link-to-climate-change-republicans-included/ft_22-08-10_extremeweather_02/" target="_blank">Pew Research Center</a></cite>
<figcaption>
There’s a partisan divide in how Americans see the role of climate change in extreme weather.
</figcaption>
</figure>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="r6PnXB">
Another 2022 poll, from <a href="https://www.hsph.harvard.edu/news/press-releases/poll-facing-extreme-weather-is-changing-americans-views-about-need-for-climate-change-action/">NPR, the Robert Wood Johnson Foundation, and the Harvard T.H. Chan School of Public Health</a>, found that among adults who experienced extreme weather over the past five years, 37 percent said climate change was a crisis and 40 percent said it was a major problem. Compare that to adults who didn’t experience severe weather: Just 16 percent described climate change as a crisis and 30 percent as a major problem.
</p>
<figure class="e-image">
<img alt="Graph comparing how people who experienced extreme weather think about climate change compared to those that didn’t." src="https://cdn.vox-cdn.com/thumbor/u2JjUDOdmnA6WoTuf1d4jk6jbAE=/800x0/filters:no_upscale()/cdn.vox-cdn.com/uploads/chorus_asset/file/24712605/weather_climate_change.jpg"/> <cite><a class="ql-link" href="https://www.hsph.harvard.edu/news/press-releases/poll-facing-extreme-weather-is-changing-americans-views-about-need-for-climate-change-action/" target="_blank">NPR/Robert Wood Johnson Foundation/Harvard T.H. Chan School of Public Health</a></cite>
<figcaption>
People who experience extreme weather say that climate change is a more urgent problem than those that don’t.
</figcaption>
</figure>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="MsftBP">
But other researchers have found mixed results on the question of how much disasters and extreme events alter how people think about global warming. A 2019 review paper in <a href="https://iopscience.iop.org/article/10.1088/1748-9326/ab466a/meta"><em>Environmental Research Letters</em></a> looking at 73 studies of climate change and public opinion found that there were often too many confounding variables, concluding “the relationship between weather and climate opinions still remains unclear.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="BN4r5q">
Major events similar to the ongoing fires in Canada did raise short-term concerns about climate change, mainly among people who were already worried about rising global average temperatures, explained the paper’s co-author <a href="https://chass.usu.edu/sociology/canri/canri_directory/peter-howe">Peter Howe</a>, who studies perceptions of climate change at Utah State University, in an email. “However, it’s not clear how durable or long-lasting the impacts are,” he said.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="6kWDlF">
It’s also uncertain how much floods, fires, heat waves, and drought influence people who weren’t already thinking about the environment. “We don’t have strong evidence yet that extreme weather events are a major cause of people who were previously dismissive about climate change changing their minds,” Howe said.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="f0Lty0">
In fact, some opinion polls show that the partisan divide on climate change as a priority has grown even though disasters exacerbated by climate change afflict red and blue regions alike.
</p>
<figure class="e-image">
<img alt="Chart comparing Republican and Democratic opinions about climate change." src="https://cdn.vox-cdn.com/thumbor/L2-vw_qnyjLkUZt3yMZK4Ol1Pu0=/800x0/filters:no_upscale()/cdn.vox-cdn.com/uploads/chorus_asset/file/24712610/sr_2023.04.18_climate_5.jpg"/> <cite><a class="ql-link" href="https://www.pewresearch.org/short-reads/2023/04/18/for-earth-day-key-facts-about-americans-views-of-climate-change-and-renewable-energy/sr_2023-04-18_climate_5/" target="_blank">Pew Research Center</a></cite>
<figcaption>
Far more Democrats say that climate change is a major threat than Republicans.
</figcaption>
</figure>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="F8Xv9t">
On the other hand, many of the tactics to limit climate change remain broadly popular. <a href="https://www.pewresearch.org/short-reads/2023/04/18/for-earth-day-key-facts-about-americans-views-of-climate-change-and-renewable-energy/">According to Pew</a>, 69 percent of Americans support the US becoming carbon neutral by 2050 and a majority favor more government support for renewable energy.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="Bkno8m">
Climate change isn’t the only issue on the table, of course. Worries about the economy can push concerns about warming to the backburner for some people, and for others, it can alter the kinds of solutions they support. “In the current period of high inflation, the public largely favors policies seen as having less of a direct impact on their own financial situation,” according to <a href="https://www.hsph.harvard.edu/news/press-releases/poll-facing-extreme-weather-is-changing-americans-views-about-need-for-climate-change-action/">the 2022 NPR poll</a>. For example, Americans were more inclined to support measures to protect against future disasters (57 percent) and less likely to favor a carbon tax that would raise their energy prices (39 percent).
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="lX5jFV">
So, on their own, the recent Canadian fires and their smoky shadow over a huge swath of the continent might not lead to large, lasting changes in public opinion. But with average global temperatures rising, the chances of fires, floods, and heat waves recurring more often or with more severity is growing. The smoke will blow away, but more days with dangerous air quality lie ahead, and it will grow even harder to avoid.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="FoOtuZ">
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="QqYR8h">
</p>
<ul>
<li><strong>Why are all these random Republicans running for president?</strong> -
<figure>
<img alt="" src="https://cdn.vox-cdn.com/thumbor/RPXuV0KvdkWm8pZPk1O4pEqv54c=/0x0:5333x4000/1310x983/cdn.vox-cdn.com/uploads/chorus_image/image/72354676/1496497961.0.jpg"/>
<figcaption>
Former New Jersey Gov. Chris Christie speaks at a town-hall-style event at the New Hampshire Institute of Politics at Saint Anselm College on June 6, 2023, in Manchester, New Hampshire.  | Michael M. Santiago/Getty Images
</figcaption>
</figure>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
In a crowded GOP primary, everybody still thinks they can win in 2024.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="erup7U">
The 2024 Republican field expanded this week with the entry of three new presidential candidates: former Vice President Mike Pence, former New Jersey Gov. Chris Christie, and North Dakota Gov. Doug Burgum. All three are polling at the bottom of the now nine-candidate field, raising the question: Why would any of them enter a race that seems impossible to win?
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="3xpMy8">
The short answer is that they may think they can beat the odds. That might seem delusional given both Pence and Christie are polling in the <a href="https://www.realclearpolitics.com/epolls/2024/president/us/2024_republican_presidential_nomination-7548.html">low single digits</a>, and Burgum is so little-known that he hasn’t even been poll-tested. But they’re holding out hope that they could become the definitive alternative to the current frontrunner, former President Donald Trump, if Florida Gov. Ron DeSantis, who is consistently polling in <a href="https://www.realclearpolitics.com/epolls/2024/president/us/2024_republican_presidential_nomination-7548.html#polls">second</a>, flames out.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="B51NkQ">
“For all these guys, it’s a very, very, very steep climb. But if DeSantis stumbles, somebody will fill that vacuum,” said Chris Russell, a GOP strategist based in New Jersey.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="A4xKmU">
That’s not an impossibility given that DeSantis has had a rocky few months. His campaign launch was defined by <a href="https://www.vox.com/politics/2023/5/24/23736883/ron-desantis-presidential-announcement-twitter">technical glitches</a> and an <a href="https://www.vox.com/politics/23736786/ron-desantis-2024-presidential-run">overly online message</a> that seemed impenetrable to most rank-and-file Republicans. There are growing concerns among donors that he’s <a href="https://www.vanityfair.com/news/2023/05/ron-desantis-unlikeable">just not that good</a> at retail politics and that he’s already doomed himself among general election voters by <a href="https://www.ft.com/content/9fa26170-5533-4e0b-a852-238b0ef15118">embracing right-wing policies</a> on issues such as abortion.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="mQxGv1">
If DeSantis’s issues continue, second-tier GOP candidates — which also include former South Carolina Gov. Nikki Haley, South Carolina Sen. Tim Scott, and right-wing activist Vivek Ramaswamy — could catch a break. It wouldn’t be the first time a long-shot candidate was suddenly catapulted into viability: At this point in the primary eight years ago, Trump was polling at 1 percent, while Jeb Bush had a double-digit lead and Scott Walker was in second. Walker later dropped out before the Iowa caucuses, the first on the Republican primary calendar, and Trump killed Bush’s campaign by dubbing him “<a href="https://www.washingtonpost.com/video/politics/trump-bush-is-poor-pathetic-low-energy-guy/2016/01/21/efd1347c-c090-11e5-98c8-7fab78677d51_video.html">Low-Energy Jeb</a>.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="4ndPn0">
The difference between 2016 and this year is Trump’s stranglehold on his base. He remains the leader of his party and is polling at <a href="https://www.realclearpolitics.com/epolls/2024/president/us/2024_republican_presidential_nomination-7548.html">over 50 percent</a>, with DeSantis about 30 percentage points behind. That lead increased after he was indicted in New York, and it’s unclear whether his trajectory will change given the additional <a href="https://www.nytimes.com/live/2023/06/08/us/trump-indictment-documents?partner=slack&amp;smid=sl-share#justice-department-charges-trump-in-documents-case">criminal charges</a> Trump said he faces on Thursday night in a separate criminal case concerning his alleged withholding of classified documents.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="mxHnAr">
Taking down DeSantis is one thing; taking out Trump is another. But the other Republican hopefuls are looking to history when they say anything can happen. Regardless of the polls, they seem to truly believe that they have a shot, though if they were to lose, some (except for maybe Pence) would welcome any consolation prizes, including positions of vice president or in the Cabinet.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="8ltIg5">
“I think all these guys think to themselves, ‘Why not me?’” Russell said.
</p>
<h3 id="FgPxTp">
Pence’s and Burgum’s campaigns seem like uphill battles
</h3>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="v768Sg">
Of the three new entries in the race, Michael DuHaime, a GOP strategist based in New Jersey, thinks that Christie has the best chance of breaking through. That might be an unsurprising opinion coming from a former top adviser to Christie. But it’s also true that Pence and Burgum have some problems Christie lacks, which means they don’t really have a plausible path to the nomination.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="X0DWby">
Pence’s unfavorability ratings, even among Republicans, are through the roof. In a series of recent <a href="https://apnorc.org/wp-content/uploads/2023/04/April-2023-Trump-Topline-.pdf">polls</a>, well over half of voters said that they viewed him unfavorably. He had 39 percent favorability in his best poll, from <a href="https://static.foxnews.com/foxnews.com/content/uploads/2023/04/Fox_April-21-24-2023_Cross-Tabs_April-26-Release.pdf">Fox News</a>, and 29 percent in his worst, from the <a href="https://s.wsj.net/public/resources/documents/WSJ_Poll_April_2023_redacted.pdf">Wall Street Journal</a>. That’s historically bad for a presidential candidate who previously served as vice president.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ekzKp6">
His decision to certify the results of the 2020 election and his criticism of Trump’s actions during the January 6, 2021, insurrection at the US Capitol was the <a href="https://www.washingtonpost.com/politics/2023/05/16/pence-republicans-perception/">turning point</a>: Despite being viewed favorably by his party during his tenure as vice president, his approval ratings took a nosedive thereafter and never revived.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="gYIQ92">
Pence has nevertheless dug in his heels in criticizing the insurrection and attacking Trump. At his <a href="https://www.washingtonpost.com/politics/2023/06/07/pence-iowa-launch-2024-republican-presidential-campaign/8ab1a212-04e8-11ee-b74a-5bdd335d4fa2_story.html">campaign launch</a> in Iowa Wednesday, he said, “I believe anyone that puts themselves over the Constitution should never be president of the United States, and anyone who asks someone else to put them over the Constitution should never be president of the United States again.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="GBziyd">
And during a CNN town hall Wednesday, he said that he had no <a href="https://twitter.com/atrupar/status/1666614246656835585?s=20">interest in pardoning</a> insurrectionists (but declined to say whether he would pardon Trump). When asked whether he would support Trump if he wins the nomination, he <a href="https://twitter.com/atrupar/status/1666635492102750211?s=20">said</a>, “I don’t think he’s going to be the nominee. I have great confidence in Republican primary voters.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="R5wmMd">
Those critiques will make it difficult for Pence to win over voters who still view Trump and the insurrectionists favorably. But Pence is also likely to have trouble finding support among those ready to move on from Trump. He worked for the former president for four years; that’s turning off the “Never Trump” segment of the party and would probably be an issue for swing voters in the general election. So it’s hard for him to <a href="https://www.vox.com/politics/2023/6/1/23745598/mike-pence-2024-election-republican-primary-candidacy-trump">make the case for his electability</a>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="MrC4aa">
Still, he persists. A prominent evangelical, Pence sees his campaign for president as a <a href="https://www.politico.com/news/2023/06/07/mike-pence-longshot-bid-trump-president-00100838">spiritual journey in addition to a political one</a>, and his advisers believe he can vanquish the other second-tier GOP candidates and emerge victorious if Trump and DeSantis self-destruct, as Adam Wren writes in Politico. But that is a very large if, and sheer self-belief doesn’t make someone president. All those qualifiers have made <a href="https://www.politico.com/news/2023/02/16/koch-network-mike-pence-trump-00083161">big donors</a> including the Koch network appear skeptical of his bid.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="kz664g">
Burgum’s problem, on the other hand, isn’t that voters don’t like him; it’s that they’ve never heard of him.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="YQ9wLh">
His <a href="https://morningconsult.com/governor-rankings/">favorability ratings</a> are high in North Dakota, but he doesn’t have the national name recognition of some of his GOP rivals. His entry into the race might be a symptom of the fact that he’s hit his “ceiling for rising in North Dakota politics,” given that he’s term-limited and would have a hard time trying to unseat North Dakota’s incumbent Republicans in the US Senate, said Mark Jendrysik, a professor of political science and public administration at the University of North Dakota.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="bGoYgN">
Burgum is hoping he can differentiate himself from the pack as a free market entrepreneur, touting his experience leading Great Plains Software, which went public in 1997 and was sold to Microsoft in 2001 for $1.1 billion in stock. His proceeds from that deal mean he’ll likely be able to self-fund his campaign through the early stages, but he would need to pick up serious donor support to stay viable after the first primaries.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="1mboVZ">
“He’s going to have to spend a lot of money just telling people who he is,” Jendrysik said. “It might be that he’s trying to raise his profile, but it just seems like a very expensive way to do that.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="fZEK9N">
Burgum might believe that there is an avenue for a “non-confrontational, competent business leader,” Jendrysik added, but that might not be enough to resonate given the current preferences of Republican primary voters who clearly still love Trump and his red-meat politics. His aides are betting that his business network will help yield <a href="https://www.nytimes.com/2023/06/07/us/politics/doug-burgum-2024-presidential-campaign.html">major donors</a>, but upon announcing his candidacy, he didn’t have the support of any super PAC or outside group. That leaves Burgum, at least for now, waiting for Trump and DeSantis to somehow be taken out of the running.
</p>
<h3 id="k72Iad">
Does Christie have an opening, or just a bone to pick with Trump?
</h3>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="qCdK6A">
Christie <a href="https://www.politico.com/news/2023/04/20/chris-christie-interview-00092999">insists</a> he sees a path to the nomination, however narrow that may be. But at least on some level, he also seems motivated to take down Trump and believes he’s the best person to do it: “You need to think about who’s got the skill to do that and who’s got the guts to do it because it’s not going to end nicely no matter what,” he<a href="https://twitter.com/steinhauserNH1/status/1640476593637429248"> said in March</a>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="1uU75O">
Once a Trump defender, he’s said he was “<a href="https://www.cnn.com/2023/06/07/politics/chris-christie-donald-trump-cnntv/index.html#:~:text=Former%20New%20Jersey%20Gov.,Turns%20out%20I%20was%20wrong.">wrong</a>” about the former president and that election night 2020 was the “breaking point” in their relationship.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="MAFZKL">
Christie has already proved willing to go head-to-head with the former president, offering criticism of his <a href="https://www.nytimes.com/2023/05/03/us/politics/chris-christie-trump-debates.html">reluctance to debate</a> and unwillingness to accept the results of the 2020 election, and calling him a “<a href="https://www.politico.com/news/2023/05/11/christie-trump-cnn-putin-00096393">coward</a>” and “puppet of Putin.” He’s said that he <a href="https://www.axios.com/2023/03/28/chris-christie-trump-support-2024">wouldn’t support Trump</a> even if the former president wins the Republican nomination in 2024. “Beware of the leader in this country, who you have handed leadership to, who has never made a mistake, who has never done anything wrong, who when something goes wrong it’s always someone else’s fault. And who has never lost,” Christie <a href="https://www.cnn.com/2023/06/06/politics/chris-christie-2024-announcement/index.html">said</a> of Trump Tuesday.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="jdNI3n">
It’s a remarkable 180-degree turn for someone who briefly headed Trump’s White House transition team and helped him prepare for debates in 2020. And it’s attracting Trump’s ire — and therefore earning Christie the media attention he wants. On Tuesday, Trump responded to Christie’s attacks with a <a href="https://news.yahoo.com/trump-responds-chris-christie-attacks-150436146.html">jab about the former governor’s weight</a>, which Christie called “childish.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="80HQsi">
Russell said it’s Christie’s bombastic style that puts him in a different class than other GOP rivals who have taken an anti-Trump stance, including Pence. Christie has <a href="https://nymag.com/intelligencer/2023/03/chris-christie-2016-loser-thinks-he-could-destroy-trump.html">publicly reminded</a> his Republican colleagues about how he took down Florida Sen. Marco Rubio on the presidential debate stage in 2016 and says that somebody needs to do the same to Trump.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="85Fk4A">
“The one thing he does bring to the race that probably nobody else does or that at least he does better than everybody else: He’s a really high-level communicator and he’s not afraid to throw a punch,” he said. “He is incredibly charismatic. His debating skills and media skills are nonparallel in a lot of ways.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="Tdk1XF">
Those skills may end up benefiting other candidates as well, especially those who might be hesitant to directly attack the former president. If Christie becomes the attack dog, he can do the dirty work for them.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="Xt1hwm">
“I don’t doubt that he will land some blows on Trump,” Russell said. “I could see him as potentially a kamikaze pilot of sorts that does damage to Trump and helps [the other GOP contenders] get closer.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="NlJNJ1">
That might be the most likely, though not preferred, outcome for someone who came in sixth the last time he ran for president. But Christie might still take that loss as a win. His previous support of Trump has seemingly brought him nothing but misery; now, he might want to inflict a little of his own.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="77OSWL">
Overall, it remains possible, though perhaps unlikely, that some confluence of events radically reshapes the race. That has candidates at the bottom of the polls waiting, hoping, and looking for their chance.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ZLYQCj">
“There’s an opportunity right now for one of these candidates to break through,” DuHaime said. “It seemed like it might be a two-person race six months ago, but DeSantis has been very disappointing in the runup to and the start of his candidacy. That has donors and voters looking for a third alternative.”
</p></li>
<li><strong>If you can’t breathe well, neither can your pet</strong> -
<figure>
<img alt="A man walks his dog in front of the skyline of lower Manhattan during heavy smog in New York on June 7, 2023." src="https://cdn.vox-cdn.com/thumbor/Efmkxn3PEdzfRvyyTqmrkQ-81SY=/431x0:7314x5162/1310x983/cdn.vox-cdn.com/uploads/chorus_image/image/72354637/1258509095.0.jpg"/>
<figcaption>
In early June, smoke from Canadian wildfires blanketed New York City, causing hazardous levels of air pollution. | Angela Weiss/AFP via Getty Images
</figcaption>
</figure>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
How to tell if your pet is suffering from wildfire smoke.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="toXCkE">
Humans aren’t the only ones breathing in deadly, dirty air this week.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="vm2eQZ">
Pets — animals who often have indoor sanctuary — may still have to venture outside when <a href="https://www.vox.com/natural-disaster">wildfire</a> smoke comes to town. Dogs need their outdoor bathroom breaks, and don’t have the protection of masks, like we do. And if living in poorly sealed buildings without air filters, other pets like cats, rabbits, guinea pigs, and birds, too, can suffer from unhealthy air.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="kFWrTR">
Smoke from more than <a href="https://www.pbs.org/newshour/world/canadian-province-of-quebec-looks-for-international-support-to-fight-over-160-wildfires">150 forest fires</a> blazing hundreds of miles away in Quebec, Canada, billowed to <a href="https://www.vox.com/future-perfect/2023/6/7/23752290/air-quality-levels-wildfire-smoke-clear-canada-ny-causes-aqi-health-symptoms">parts of the US earlier this week</a>, leading to extremely high levels of air pollution. <a href="https://abc7ny.com/air-quality-nyc-forecast-alert-canada-wildfire-smoke/13357814/">New York City</a>, <a href="https://6abc.com/air-quality-philadelphia-alert-pennsylvania-new-jersey-delaware/13357784/">Philadelphia</a>, and <a href="https://www.wusa9.com/article/weather/dc-air-quality-impacted-by-wildfire-smoke/65-9b61d37c-6571-4e14-a7ff-1ef99010608a">Washington, DC</a> all saw air pollution levels reach the “hazardous” level on the <a href="https://www.airnow.gov/aqi/aqi-basics/">Air Quality Index</a>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="c3F2M1">
While pet parents and animals in the US are a safe distance from the flames themselves, the threat of air pollution cannot be underestimated. In humans, air pollution can <a href="https://www.vox.com/science/2023/6/7/23752310/wildfire-canada-air-quality-smoke-asthma-copd-lung-heart-disease">cause</a> dizziness, coughing, headaches, and in more severe cases and vulnerable groups, heart and lung problems. Air pollution is also a silent killer: It’s responsible for <a href="https://www.vox.com/energy-and-environment/2020/8/12/21361498/climate-change-air-pollution-us-india-china-deaths">nearly 250,000 premature deaths</a> in the US and <a href="https://www.who.int/news-room/fact-sheets/detail/ambient-(outdoor)-air-quality-and-health">6.7 million premature deaths</a> globally each year.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="wRQHHs">
Poor air quality can also harm your pet. As such, air quality alerts apply to people as well as their pets. If the air isn’t safe for you, it’s not safe for them.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="XLE8Qs">
“A lot of people just don’t realize that animals can experience things almost exactly in the same ways that we do,” said Lisa Lippman, a veterinarian and director of virtual medicine at <a href="https://bondvet.com/about-us">Bond Vet</a>. “They have the same organ systems that we do, and they’re really, really susceptible, especially [to air pollution] if they’re in the at-risk categories.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="du6W2k">
Importantly, fretting about air quality and what to do is just the beginning of what experts believe, due to <a href="https://www.vox.com/climate">climate change</a>, will be a more <a href="https://www.vox.com/future-perfect/2023/6/7/23752290/air-quality-levels-wildfire-smoke-clear-canada-ny-causes-aqi-health-symptoms">fire-filled future</a>. As such, it’s important that pet parents learn how to protect themselves and their furry/scaly/feathered friends.
</p>
<h3 id="3TzIxr">
How to keep your pets safe from wildfire smoke
</h3>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="K23Neo">
Like humans, the first line of protection for pets is staying indoors whenever possible. Even indoors, birds are <a href="https://www.nytimes.com/2023/06/07/us/wildfire-smoke-pets-safety.html">particularly at risk</a>. Keeping them in a room with sealed windows and an air purifier can help.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="rK7A0I">
“You get birds in smoke and they’re going to crumple,” said Debra Zoran, a veterinarian and professor in small animal clinical sciences in the School of Veterinary Medicine and Biomedical Sciences at Texas A&amp;M University. But “with good filtration and working air conditioners and all those sorts of things, they’re probably going to be okay [indoors].”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="kjReC9">
<a href="https://www.vox.com/health/23753938/air-conditioners-filter-wildfire-smoke-indoor-quality-pollution">As Vox’s Keren Landman reports</a>, you’ll want to switch from ventilation mode to <a href="https://www.epa.gov/indoor-air-quality-iaq/create-clean-room-protect-indoor-air-quality-during-wildfire">recirculation mode</a> on your HVAC units. If you have a window AC unit, make sure those flimsy side panels are well sealed. You’ll also want to avoid running exhaust fans like the ones in your bathroom or kitchen.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="J6lWdu">
For dogs that require the occasional quick trip outdoors, keep it brief and mission-oriented.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="HDiDyV">
That can be difficult if your pup doesn’t quite understand why you’re in such a hurry. If they’re reluctant, <a href="https://www.chewy.com/b/pee-pads-diapers-360">potty pads</a> might also be a good resource to stock up on. Smoke is usually less intense really early in the morning and late at night, so think about doing your outside walks during those times.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="IbCyOc">
Back inside, you can wipe down their fur (especially around the eyes and mouth) to help prevent irritation from airborne particles. Puppies and older dogs, along with those with smushed faces — like pugs, Boston terriers, and bulldogs — are at greater risk.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ogzesy">
“Animals with flat faces, like pugs and Persian cats, are sensitive to poor air quality since they cannot pant as effectively,” Lori Bierbrier, a senior medical director for the <a href="https://www.aspca.org/news/aspca-community-veterinary-centers-fill-much-needed-space-new-york-communities">ASPCA Community Medicine</a> team, told Vox in a written statement. “These pets, along with the elderly, the overweight, and those with heart or lung diseases, should be kept cool in air-conditioned rooms as much as possible.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="kIglkV">
Bierbrier recognizes that keeping your pet indoors most of the day, especially if they’re used to outdoor play sessions or walks, can be challenging. Boredom is already <a href="https://www.vox.com/future-perfect/2023/4/11/23673393/pets-dogs-cats-animal-welfare-boredom">a neglected animal welfare issue</a>, even without added confinement.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="pQ4Ivg">
“Ramping down that exercise could leave your pet with pent-up energy,” she said. “Interactive toys or healthy chews can help keep your dog active and engaged while limiting outside time.” Specifically for dogs, Bierbrier recommends stuffing toys with the animal’s favorite food and then freezing it. These toys keep pets busy and soothe them, she said.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="Nw7Vzm">
One thing you should not do, Zoran said, is put a mask on your dog when you take them outside. Even if you manage to get a mask on tight enough to prevent particulates from getting around the edges, “a mask that tight would cause most dogs to lose their minds. If it’s tight enough to keep particulates from getting around it, they’re not going to go for it because they can’t pant,” she said.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="8o7H78">
Cats and dogs alike have strong respiratory systems, but hydration is key. “Their nasal passages and respiratory trees are amazingly resilient to removing those particulates, as long as they’re well hydrated. If the airways get dehydrated, they can’t do their jobs as well,” said Zoran.
</p>
<h3 id="O9clxp">
How to tell if your pets are having a bad reaction to wildfire smoke or poor air quality
</h3>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="QoY9W1">
Since animals can’t exactly say, “Hey, I’m having a tough time breathing!” directly to humans, it’s sometimes hard to tell when your pet isn’t feeling well, or if symptoms are a sign of something more serious as opposed to general irritation.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="hhsJp6">
The American Veterinary Medical Association <a href="https://www.avma.org/resources/pet-owners/emergencycare/wildfire-smoke-and-animals">instructs pet owners</a> to consult their vet if their animal is experiencing fatigue, eye irritation, coughing, gagging, or labored breathing after exposure to smoke-caused air pollution. If cats are breathing through their mouths, they’re having trouble breathing. “That’s go-to-the-vet land,” said Zoran.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="yKya4d">
“With dogs, you can’t use that same criteria, because they breathe through their mouths all the time,” Zoran continued. “If they’re coughing, and are obsessively open-mouth breathing, or are unable to lay down and rest, that probably means they’re uncomfortable and don’t have the ability to relax, and that is telling you that something is not going well.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="RLRwUt">
There are ways for owners to relieve their discomfort at home. For dogs and cats that show signs of eye irritation (which include redness, tearing, and pawing at their face), squeezing a cotton ball with lukewarm water over their eyes to flush them out can relieve discomfort, Jerry Klein, the chief veterinary officer at the American Kennel Club, <a href="https://www.nytimes.com/2023/06/07/us/wildfire-smoke-pets-safety.html">told the New York Times</a>.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="ej8aF8">
It’s also important to recognize when the best option for you and your pet is to leave the area. If you and your pets are in immediate danger due to a wildfire or any other type of natural disaster, having a confirmed, pet-friendly location to evacuate to is vital.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="S14lzu">
Your animal’s evacuation kit should contain three to seven days of food, any medicine your pet needs, medical records, and a pet carrier (a <a href="https://www.avma.org/resources-tools/pet-owners/emergency-care/pets-and-disasters">full list</a> of what to include can be found on the American Veterinary Medical Association’s website).
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="f9OoLA">
In any case, pet parents should be monitoring these disasters closely, paying attention to both the air quality — which they can do via <a href="https://www.airnow.gov/">AirNow</a> — and their pet’s behavior.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="54o1p5">
“Don’t hesitate to reach out to the vet if you have any questions,” said Lippman, who <a href="https://www.instagram.com/reel/CtMYdeKLqNU/?igshid=NjZiM2M3MzIxNA%3D%3D">shared advice</a> on how to deal with the current air pollution on her Instagram. “We would so rather you be safe than sorry.”
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom" id="bpyY3j">
</p></li>
</ul>
<h1 data-aos="fade-right" id="from-the-hindu-sports">From The Hindu: Sports</h1>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>WTC final, Ind vs Aus Day 3 | Rahane rises to occasion to take India to 260 for six at lunch</strong> - India, who resumed the day at 151 for five in response to Australia’s 469, need 10 runs to avoid follow-on.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Disney+ Hotstar to offer free streaming of Cricket World Cup, Asia Cup to mobile users</strong> - India will host this year’s Asia Cup in September while also hosting the ICC Men’s Cricket World Cup which will take place from October 5 to November 19</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Morning Digest | Former U.S. President Donald Trump charged in classified documents probe; Father of minor wrestler says filed false sexual harassment allegations against WFI chief, and more</strong> - Here’s a select list of stories to read before you start your day</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>French Open | Swiatek feels heat but ends Haddad Maia run to reach final</strong> - Swiatek sets up Muchova showdown for French Open crown</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Haaland looks set to replace Messi and Ronaldo as soccer’s next global superstar</strong> - Haaland’s five goals against Leipzig in the Champions League matched the record held by Messi and Luiz Adriano for the most in a single game in European soccer’s top club competition.</p></li>
</ul>
<h1 data-aos="fade-right" id="from-the-hindu-national-news">From The Hindu: National News</h1>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Switching from coal power contracts to renewable energy can save Kerala ₹9,000 crore in five years, says study</strong> - A report on the findings, released here on Friday, recommended that the State go in for a phased energy transition plan with the goal of phasing out coal power purchases by 2030</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Palaniswami to chair a meeting of district secretaries on June 13</strong> -</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Kochi start-up forays into space with rocketry and satellite development</strong> - It plans to launch a customised satellite aboard a rocket propelled by a helium or hydrogen-powered balloon</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Reopening of schools in T.N. | 1,500 special buses to be operated from June 9 to 11</strong> - Transport Department said 650 special buses would be run for three days to Chennai from the other parts of the State and 850 special buses would be operated from Madurai, Thirunelveli, Tiruchi and Salem to important destinations, including Bengaluru.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Maitreyan joins BJP, a return after two decades in AIADMK</strong> - Dr. Maitreyan had been with the BJP prior to 2000.</p></li>
</ul>
<h1 data-aos="fade-right" id="from-bbc-europe">From BBC: Europe</h1>
<ul>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Ukraine army attacks Russian forces in southern Zaporizhzhia region</strong> - Military observers say Kyiv is trying to split the occupying forces in Zaporizhzhia.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>France stabbing: Children attacked in Annecy park in stable condition</strong> - All four children are in hospital and officials have told the BBC they are in a stable condition.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Ukraine dam: Floods devastate tracts of rich farmland</strong> - The long-term consequences for agriculture will be severe in one of Ukraine’s most fertile areas.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Eurozone in recession as rising prices hit spending</strong> - Revised data shows the eurozone’s economy contracted at the end of last year and the start of 2023.</p></li>
<li data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Ukraine war: Russia says ammonia pipeline blast may end grain deal</strong> - Moscow blames Ukraine for damage to the key Togliatti-Odesa pipeline on Monday, which Kyiv denies.</p></li>
</ul>
<h1 data-aos="fade-right" id="from-ars-technica">From Ars Technica</h1>
<ul>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>I just bought the only physical encyclopedia still in print, and I regret nothing</strong> - The still-updated World Book Encyclopedia is my antidote to the information apocalypse. - <a href="https://arstechnica.com/?p=1938612">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Dealmaster: Savings on practical Father’s Day tech gift ideas</strong> - Our curated Father’s Day list of the favorite toys and tech dads will love. - <a href="https://arstechnica.com/?p=1946339">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>A telescope happened to be pointing at the brightest supernova yet observed</strong> - The BOAT—brightest of all time—reveals the mechanics of gamma-ray bursts. - <a href="https://arstechnica.com/?p=1946626">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Google makes office attendance part of performance reviews</strong> - Employees need to be in the office at least three days a week. - <a href="https://arstechnica.com/?p=1946397">link</a></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Tesla to add General Motors to its charger standard next year</strong> - GM EV drivers will need a dongle at first; NACS ports will show up in 2025. - <a href="https://arstechnica.com/?p=1946589">link</a></p></li>
</ul>
<h1 data-aos="fade-right" id="from-jokes-subreddit">From Jokes Subreddit</h1>
<ul>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Hey Guys…Next time you’re having an argument with your wife, start undressing.</strong> - <!-- SC_OFF --></p>
<div class="md">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
She will instantly have a headache and then go to sleep.
</p>
</div>
<!-- SC_ON -->
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"> submitted by <a href="https://www.reddit.com/user/Paladium9999"> /u/Paladium9999 </a> <br/> <span><a href="https://www.reddit.com/r/Jokes/comments/144s42o/hey_guysnext_time_youre_having_an_argument_with/">[link]</a></span> <span><a href="https://www.reddit.com/r/Jokes/comments/144s42o/hey_guysnext_time_youre_having_an_argument_with/">[comments]</a></span></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Everyone’s heard of Cunningham’s Law - “Anything that can go wrong, will go wrong”. But have you heard of Cole’s Law?</strong> - <!-- SC_OFF --></p>
<div class="md">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
It’s thinly slice cabbage and mayo.
</p>
</div>
<!-- SC_ON -->
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"> submitted by <a href="https://www.reddit.com/user/LoneSoarvivor"> /u/LoneSoarvivor </a> <br/> <span><a href="https://www.reddit.com/r/Jokes/comments/1450su5/everyones_heard_of_cunninghams_law_anything_that/">[link]</a></span> <span><a href="https://www.reddit.com/r/Jokes/comments/1450su5/everyones_heard_of_cunninghams_law_anything_that/">[comments]</a></span></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>A husband on a work trip when decides to call his wife at home…</strong> - <!-- SC_OFF --></p>
<div class="md">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
A woman the husband doesn’t recognize picks up the phone.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“Who is this?” asks the husband.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“I’m the maid. I was hired yesterday,” says the maid.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“Ah. Could you put my wife on the phone?” asks the husband
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“No, she’s busy having sex with someone in the room upstairs,” replies the maid.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
Enraged, the husband tells the maid that if she kills both the wife and the other man, she’ll be given 3000 dollars.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
The husband hears the screams and the sounds of a struggle upstairs, and then the maid comes back down to the phone.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“Okay, now dump the bodies in the pool,” the husband instructs.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“What pool?” the maid asks, in confusion.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
“Whoops, wrong number.”
</p>
</div>
<!-- SC_ON -->
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"> submitted by <a href="https://www.reddit.com/user/CoinCoffer1234567890"> /u/CoinCoffer1234567890 </a> <br/> <span><a href="https://www.reddit.com/r/Jokes/comments/144w64w/a_husband_on_a_work_trip_when_decides_to_call_his/">[link]</a></span> <span><a href="https://www.reddit.com/r/Jokes/comments/144w64w/a_husband_on_a_work_trip_when_decides_to_call_his/">[comments]</a></span></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>Why did the chicken cross the road?</strong> - <!-- SC_OFF --></p>
<div class="md">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
No one knows.
</p>
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
<em>But the road will have its vengeance.</em>
</p>
</div>
<!-- SC_ON -->
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"> submitted by <a href="https://www.reddit.com/user/KairuSmairukon"> /u/KairuSmairukon </a> <br/> <span><a href="https://www.reddit.com/r/Jokes/comments/144mp1h/why_did_the_chicken_cross_the_road/">[link]</a></span> <span><a href="https://www.reddit.com/r/Jokes/comments/144mp1h/why_did_the_chicken_cross_the_road/">[comments]</a></span></p></li>
<li><p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"><strong>My grandfather has the heart of a lion, the stomach of a bear…</strong> - <!-- SC_OFF --></p>
<div class="md">
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom">
… and a lifetime ban from the local zoo
</p>
</div>
<!-- SC_ON -->
<p data-aos="fade-left" data-aos-anchor-placement="bottom-bottom"> submitted by <a href="https://www.reddit.com/user/darthurface"> /u/darthurface </a> <br/> <span><a href="https://www.reddit.com/r/Jokes/comments/144r5zf/my_grandfather_has_the_heart_of_a_lion_the/">[link]</a></span> <span><a href="https://www.reddit.com/r/Jokes/comments/144r5zf/my_grandfather_has_the_heart_of_a_lion_the/">[comments]</a></span></p></li>
</ul>
<script>AOS.init();</script></body></html>

4
index.html
View File

File diff suppressed because one or more lines are too long